16.6 C
New York
Saturday, May 15, 2021
- Advertisement -

TAG

FDA

AstraZeneca [NASDAQ: AZN] Secures FDA Approval for Farxiga

AstraZeneca Plc revealed that finally, it has secured the authorization of the FDA for FARXIGA. The FDA authorization is dependent on the results...

Why Protalix Stock is Crashing Today?

Protalix BioTherapeutics, Inc. stock has plunged 39.66% during the trading session of Wednesday. The negative performance of the company indicated the negative reaction...

ADMA Biologics [NASDAQ: ADMA] Gets FDA Approval for Increased IVIG Production Scale

ADMA Biologics, Inc. disclosed Wednesday that it has got the FDA authorization for the expanded manufacturing process of the firm. It will allow...

Moderna [NASDAQ: MRNA] Gives Storage Update of its COVID-19 Vaccine

Moderna Inc. disclosed that its COVID-19 vaccine has been granted the authorization by FDA to be stored at room temperature conditions once separated...

BeyondSpring [NASDAQ: BYSI] Submits NDA to FDA for Plinabulin and G-CSF Combination

BeyondSpring Inc. disclosed that it has submitted a New Drug Application to the US FDA and China National Medical Products Administration (NMPA). The...

QIAGEN [NYSE: QGEN] Gets FDA EUA for NeuMoDx

QIAGEN N.V. revealed that it has obtained EUA from FDA for NeuMoDx Flu A-B/RSV/SARS-CoV-2. NeuMoDx will assist health-care experts in rapidly recognize and...

Bristol Myers [NYSE: BMY] and Bluebird’s Abecma Receives FDA Approval

Bristol Myers Squibb and Bluebird Bio, Inc. disclosed that their Abecma has got the authorization of the US FDA. FDA has accepted...

AVEO Pharmaceuticals [NASDAQ: AVEO] Receives FDA Approval For FOTIVDA

AVEO Pharmaceuticals, Inc. disclosed that it has received FDA authorization for the treatment of sufferers suffering from relapsed or refractory advanced renal cell...

Second Sight [NASDAQ: EYES] Gets FDA Approval For Argus 2s Retinal Prosthesis System

Second Sight Medical Products disclosed that FDA has granted the authorization to FDA for Argus 2s Retinal Prosthesis System. The authorization of Argus...

Johnson & Johnson [NYSE: JNJ] COVID-19 Vaccine Gets FDA Panel Recommendation

Johnson & Johnson revealed that its COVID-19 vaccine candidate has got a green signal from the panel of the FDA. The firm disclosed...

Latest news

- Advertisement -